Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.2500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.3000/ 5
- Ask / Lots4.4400/ 10
- Open / Previous Close4.4100 / 4.2500
- Day Range
- 52 Week Range
- Volume2,379,757
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 119722 | 4.46 |
| 09:34 ET | 38239 | 4.3006 |
| 09:36 ET | 117632 | 4.34 |
| 09:38 ET | 31056 | 4.31 |
| 09:39 ET | 5357 | 4.27 |
| 09:41 ET | 22407 | 4.29 |
| 09:43 ET | 7561 | 4.318 |
| 09:45 ET | 12226 | 4.34 |
| 09:48 ET | 4807 | 4.33 |
| 09:50 ET | 111293 | 4.32 |
| 09:52 ET | 5136 | 4.35 |
| 09:54 ET | 8413 | 4.355 |
| 09:56 ET | 9299 | 4.38 |
| 09:57 ET | 44265 | 4.4386 |
| 09:59 ET | 24769 | 4.38 |
| 10:01 ET | 16330 | 4.4185 |
| 10:03 ET | 4198 | 4.42 |
| 10:06 ET | 120071 | 4.4 |
| 10:08 ET | 35695 | 4.35 |
| 10:10 ET | 12228 | 4.3 |
| 10:12 ET | 35943 | 4.3 |
| 10:14 ET | 10395 | 4.3 |
| 10:15 ET | 4090 | 4.3 |
| 10:17 ET | 3780 | 4.3 |
| 10:19 ET | 48892 | 4.295 |
| 10:21 ET | 5794 | 4.315 |
| 10:24 ET | 2445 | 4.315 |
| 10:26 ET | 1071 | 4.34 |
| 10:28 ET | 5026 | 4.345 |
| 10:30 ET | 4369 | 4.35 |
| 10:32 ET | 5788 | 4.345 |
| 10:33 ET | 1400 | 4.345 |
| 10:35 ET | 16320 | 4.315 |
| 10:37 ET | 7059 | 4.35 |
| 10:39 ET | 600 | 4.355 |
| 10:42 ET | 900 | 4.355 |
| 10:44 ET | 3505 | 4.36 |
| 10:46 ET | 16501 | 4.39 |
| 10:48 ET | 6092 | 4.41 |
| 10:50 ET | 12336 | 4.4101 |
| 10:51 ET | 4027 | 4.41 |
| 10:53 ET | 12379 | 4.415 |
| 10:55 ET | 1700 | 4.415 |
| 10:57 ET | 4239 | 4.415 |
| 11:00 ET | 20931 | 4.435 |
| 11:02 ET | 6787 | 4.43 |
| 11:04 ET | 8900 | 4.405 |
| 11:06 ET | 5450 | 4.4093 |
| 11:08 ET | 327 | 4.407 |
| 11:09 ET | 5910 | 4.42 |
| 11:11 ET | 7957 | 4.4 |
| 11:13 ET | 13423 | 4.405 |
| 11:15 ET | 17564 | 4.395 |
| 11:18 ET | 8213 | 4.4 |
| 11:20 ET | 22867 | 4.415 |
| 11:22 ET | 3855 | 4.425 |
| 11:24 ET | 220 | 4.4299 |
| 11:26 ET | 8549 | 4.395 |
| 11:27 ET | 8244 | 4.415 |
| 11:29 ET | 20433 | 4.3241 |
| 11:31 ET | 8776 | 4.2999 |
| 11:33 ET | 22757 | 4.27 |
| 11:36 ET | 33374 | 4.35 |
| 11:38 ET | 36308 | 4.4 |
| 11:40 ET | 19121 | 4.4 |
| 11:42 ET | 18083 | 4.39 |
| 11:44 ET | 12623 | 4.4034 |
| 11:45 ET | 7000 | 4.4 |
| 11:47 ET | 24906 | 4.4 |
| 11:49 ET | 15420 | 4.33 |
| 11:51 ET | 2727 | 4.31 |
| 11:54 ET | 1090 | 4.295 |
| 11:56 ET | 15793 | 4.31 |
| 11:58 ET | 4700 | 4.3105 |
| 12:00 ET | 2750 | 4.3 |
| 12:02 ET | 12159 | 4.305 |
| 12:03 ET | 14242 | 4.295 |
| 12:05 ET | 30250 | 4.335 |
| 12:07 ET | 200 | 4.32 |
| 12:09 ET | 29960 | 4.305 |
| 12:12 ET | 39643 | 4.31 |
| 12:14 ET | 18261 | 4.255 |
| 12:16 ET | 6437 | 4.295 |
| 12:18 ET | 7498 | 4.2946 |
| 12:20 ET | 3520 | 4.295 |
| 12:21 ET | 200 | 4.295 |
| 12:23 ET | 9090 | 4.32 |
| 12:25 ET | 500 | 4.33 |
| 12:30 ET | 1200 | 4.355 |
| 12:32 ET | 5410 | 4.375 |
| 12:34 ET | 22410 | 4.345 |
| 12:36 ET | 3000 | 4.37 |
| 12:38 ET | 11523 | 4.345 |
| 12:39 ET | 3400 | 4.345 |
| 12:41 ET | 11064 | 4.335 |
| 12:43 ET | 4920 | 4.36 |
| 12:45 ET | 900 | 4.33 |
| 12:48 ET | 7989 | 4.33 |
| 12:50 ET | 17963 | 4.2898 |
| 12:52 ET | 9574 | 4.285 |
| 12:54 ET | 7090 | 4.285 |
| 12:56 ET | 10655 | 4.3 |
| 12:59 ET | 7294 | 4.295 |
| 01:01 ET | 3000 | 4.3 |
| 01:03 ET | 753 | 4.3 |
| 01:06 ET | 5486 | 4.31 |
| 01:08 ET | 3189 | 4.315 |
| 01:10 ET | 1498 | 4.305 |
| 01:12 ET | 11350 | 4.285 |
| 01:14 ET | 16440 | 4.315 |
| 01:15 ET | 1720 | 4.3109 |
| 01:17 ET | 1900 | 4.3236 |
| 01:19 ET | 3100 | 4.325 |
| 01:21 ET | 3401 | 4.33 |
| 01:24 ET | 1319 | 4.32 |
| 01:26 ET | 3369 | 4.32 |
| 01:28 ET | 6903 | 4.29 |
| 01:30 ET | 600 | 4.29 |
| 01:32 ET | 7749 | 4.3 |
| 01:33 ET | 10882 | 4.2998 |
| 01:35 ET | 988 | 4.3 |
| 01:42 ET | 3246 | 4.3 |
| 01:46 ET | 2805 | 4.315 |
| 01:48 ET | 1409 | 4.315 |
| 01:50 ET | 4041 | 4.33 |
| 01:51 ET | 3450 | 4.325 |
| 01:53 ET | 3300 | 4.33 |
| 01:55 ET | 100 | 4.325 |
| 01:57 ET | 352 | 4.325 |
| 02:00 ET | 2100 | 4.325 |
| 02:02 ET | 2979 | 4.325 |
| 02:04 ET | 6744 | 4.3231 |
| 02:06 ET | 2000 | 4.325 |
| 02:08 ET | 1300 | 4.325 |
| 02:09 ET | 220 | 4.3202 |
| 02:11 ET | 3449 | 4.325 |
| 02:13 ET | 100 | 4.325 |
| 02:15 ET | 5153 | 4.325 |
| 02:18 ET | 1212 | 4.335 |
| 02:20 ET | 4145 | 4.3202 |
| 02:22 ET | 2448 | 4.32 |
| 02:24 ET | 2562 | 4.3047 |
| 02:26 ET | 31042 | 4.3 |
| 02:27 ET | 10059 | 4.295 |
| 02:29 ET | 3850 | 4.285 |
| 02:31 ET | 6871 | 4.285 |
| 02:33 ET | 5054 | 4.29 |
| 02:36 ET | 250 | 4.295 |
| 02:38 ET | 300 | 4.295 |
| 02:40 ET | 1114 | 4.295 |
| 02:42 ET | 7372 | 4.3 |
| 02:44 ET | 2500 | 4.3 |
| 02:45 ET | 300 | 4.295 |
| 02:47 ET | 1742 | 4.3 |
| 02:49 ET | 3849 | 4.3 |
| 02:51 ET | 1475 | 4.305 |
| 02:54 ET | 600 | 4.3 |
| 02:56 ET | 1850 | 4.3 |
| 02:58 ET | 500 | 4.3 |
| 03:00 ET | 1525 | 4.2975 |
| 03:02 ET | 24017 | 4.3 |
| 03:03 ET | 19401 | 4.3 |
| 03:05 ET | 7808 | 4.305 |
| 03:07 ET | 2550 | 4.305 |
| 03:09 ET | 6309 | 4.3 |
| 03:12 ET | 600 | 4.3075 |
| 03:14 ET | 4902 | 4.31 |
| 03:16 ET | 4998 | 4.2963 |
| 03:18 ET | 13335 | 4.3 |
| 03:20 ET | 3084 | 4.3 |
| 03:21 ET | 1956 | 4.2975 |
| 03:23 ET | 5737 | 4.3 |
| 03:25 ET | 1668 | 4.3 |
| 03:27 ET | 826 | 4.3 |
| 03:30 ET | 1880 | 4.3 |
| 03:32 ET | 3682 | 4.3 |
| 03:34 ET | 200 | 4.29 |
| 03:36 ET | 12461 | 4.245 |
| 03:38 ET | 16531 | 4.255 |
| 03:39 ET | 682 | 4.255 |
| 03:41 ET | 7046 | 4.25 |
| 03:43 ET | 17863 | 4.25 |
| 03:45 ET | 6544 | 4.245 |
| 03:48 ET | 16209 | 4.245 |
| 03:50 ET | 9492 | 4.25 |
| 03:52 ET | 7220 | 4.25 |
| 03:54 ET | 33116 | 4.25 |
| 03:56 ET | 16981 | 4.25 |
| 03:57 ET | 13902 | 4.259 |
| 03:59 ET | 5127 | 4.25 |
Jun 14, 2024
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 13, 2024
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow JonesDJ Mereo BioPharma Group Is Maintained at Buy by Needham, from 6:47AM ET on Wednesday Jun 12, 2024 by Dow Jones
6:47AM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 596.2M | -16.1x | --- |
CARGO Therapeutics Inc | 766.6M | -5.5x | --- |
Scholar Rock Holding Corp | 753.7M | -4.2x | --- |
Hillevax Inc | 750.3M | -4.6x | --- |
Nuvation Bio Inc | 746.5M | -9.3x | --- |
Dianthus Therapeutics Inc | 763.1M | -7.9x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $596.2M |
|---|---|
Revenue (TTM) | $9.0M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.91 |
EPS | $-0.26 |
Book Value | $0.63 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | 65.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
